KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $951.0 million.

  • Abbott Laboratories' Long-Term Investments rose 427.63% to $951.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $951.0 million, marking a year-over-year increase of 427.63%. This contributed to the annual value of $886.0 million for FY2024, which is 1088.86% up from last year.
  • Per Abbott Laboratories' latest filing, its Long-Term Investments stood at $951.0 million for Q3 2025, which was up 427.63% from $958.0 million recorded in Q2 2025.
  • Abbott Laboratories' 5-year Long-Term Investments high stood at $958.0 million for Q2 2025, and its period low was $734.0 million during Q2 2022.
  • Over the past 5 years, Abbott Laboratories' median Long-Term Investments value was $812.0 million (recorded in 2021), while the average stood at $829.6 million.
  • As far as peak fluctuations go, Abbott Laboratories' Long-Term Investments tumbled by 881.99% in 2022, and later surged by 1573.6% in 2024.
  • Abbott Laboratories' Long-Term Investments (Quarter) stood at $816.0 million in 2021, then decreased by 6.13% to $766.0 million in 2022, then grew by 4.31% to $799.0 million in 2023, then rose by 10.89% to $886.0 million in 2024, then increased by 7.34% to $951.0 million in 2025.
  • Its Long-Term Investments was $951.0 million in Q3 2025, compared to $958.0 million in Q2 2025 and $907.0 million in Q1 2025.